Scotland-based Pneumagen, which focuses on treating infectious diseases by targeting the human glycome, has raised 4 million pounds in funding. Thairm Bio led the round with participation from the Scottish Investment Bank.
Source: Press Release
Pneumagen pulls in funding
Scotland-based Pneumagen, which focuses on treating infectious diseases by targeting the human glycome, has raised 4 million pounds in funding.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: